Drew Ramos is a Ph.D. candidate in the UC Berkeley–UCSF Joint Ph.D. Program in Bioengineering. He received his undergraduate degree in bioengineering, where he conducted research in biomaterials and regenerative medicine, and later interned at the University of Pennsylvania contributing to drug delivery research for lung cancer imaging. In Dr. Adam Abate's lab, Drew is developing a novel diagnostic platform for rapid, multiplexed detection of central nervous system pathogens, addressing the global burden of undiagnosed encephalitis and meningitis. As an Alber Fellow, he is collaborating with UCSF infectious disease experts to clinically validate the assay and integrating machine learning to expand its applications for transplant infection monitoring and antimicrobial resistance genotyping. Drew is passionate about developing scalable, affordable technologies that can be deployed in the regions that need them most, ensuring patients receive timely diagnoses regardless of geography or infrastructure.